Australia’s experience of DAA roll out shows high efficacy

The first real-world results for direct-acting antiviral (DAA) treatment of hepatitis C  in Australia show efficacy rates are on par with clinical trials but almost one in seven patients are being lost to follow-up. Between March 2016 and March 2017, gastroenterologist and hepatologist Dr James Haridy and colleagues in South Australia followed up 1909 patients with ...

Already a member?

Login to keep reading.

© 2021 the limbic